India Court Puts $3.2B Sun Pharma, Ranbaxy Merger On Hold
An Indian court on Friday halted Sun Pharmaceuticals Inc.'s $3.2 billion all-stock takeover of struggling rival Ranbaxy Laboratories Ltd., following a petition lodged earlier last week by two Sun Pharma shareholders...To view the full article, register now.
Already a subscriber? Click here to view full article